$15M Class Settlement Reached In Bayer Combination Aspirin MDL In Brooklyn

$15M Class Settlement Reached In Bayer Combination Aspirin MDL In Brooklyn

BROOKLYN, N.Y. - Bayer Corp. LLC has agreed to settle a consumer fraud lawsuit involving its Bayer Aspirin with Heart Advantage and Bayer Women's Low Dose Aspirin + Calcium for $15 million, according to a May 16 preliminary approval motion filed in a New York federal multidistrict court (In Re: Bayer Combination Aspirin Products Marketing and Sales Practices Litigation, No. 09-md-2023, E.D. N.Y.).

Find full version on lexis Advance®
Access this news story on lexis.com®